Source briefing
Japanese City Undermines its Program to Protect Babies
The city of Izumisano in Japan’s Osaka Prefecture announced on July 27 that it would create a new nyujiin—an infant care institution for children under age 3—for the estimated 40 babies it expects to receive annually. Click to expand…
Read →
Source briefing
Hungary’s Parliament Adds Safeguards to Asset Recovery Office
Click to expand Image Lawmakers vote in the chamber of the Hungarian National Assembly on legislation related to establishing the National Asset Recovery and Protection Office in Budapest, Hungary, July 28, 2026. © 2026 Balint Szentgallay/NurPhoto via AP…
Read →Source briefing
Lebanon: Israel’s Killing of Journalist an Apparent War Crime
Click to expand Image Amal Khalil, a veteran correspondent for the daily newspaper Al-Akhbar, in the southern Lebanese border village of Jebbayn in 2024 © The Israeli military’s April 22, 2026 attacks in Lebanon that killed one journalist…
Read →Source briefing
After cancer drug counterfeiting scandal, India imposes new tracing requirements
Reporting by ICIJ and The Indian Express illustrated how Indian counterfeiters exploited the high price of the lifesaving cancer drug Keytruda and the desperation of patients seeking it.
Read →Source briefing
‘I terminated this channel’: Inside the Fake Copyright Racket Silencing News Outlets
Hired hands in an underground takedown market are charging up to $5,000 to scrub reporting from social media by filing fake copyright claims.
Read →
Source briefing
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 27, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Date of authorisation: 18/02/2019, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Date of authorisation: 18/02/2019, Revision: 7, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 32, Status: Authorised
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 32, Status: Authorised
Read →